Syneron to Participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

Syneron to Participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

Syneron announced today that Asaf Alperovitz, Chief Financial Officer, is scheduled to participate in the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference in San Francisco.

Read More

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use the patented elos technology with applications for treatment of wrinkles, skin, age spots, cellulite, acne, rosacea, hair removal, leg veins, spider veins, and much more.  elos technology combines radio frequency and light energies, and is sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.